Brief: Collegium Reports Fourth Quarter And Full-Year 2022 Financial Results
Feb 23 (Reuters) - Collegium Pharmaceutical Inc
COLL.O :
* COLLEGIUM REPORTS FOURTH QUARTER AND FULL-YEAR 2022
FINANCIAL
RESULTS
* REAFFIRMED 2023 FINANCIAL GUIDANCE
* GENERATED QUARTERLY NET REVENUE OF $129.6 MILLION
* QQ4 GAAP NET LOSS WAS $7.2 MILLION, WITH $0.21 GAAP LOSS
PER
SHARE (BASIC AND DILUTED)
* Q4 EARNINGS PER SHARE VIEW $-0.15, REVENUE VIEW $125.2
MILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7Fs8c5
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%